Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.

Journal of endocrinological investigation·2024

Same author

Computational Model Based on Optical Coherence Tomography (OCT) Skin Scanning to Identify and Quantify Acute Radiation Dermatitis (ARD): A Prospective Diagnostic Study.

Actas dermo-sifiliograficas·2024

Same author

Fungal Planet description sheets: 1383-1435.

Persoonia·2024

Same author

Compartments of the crural fascia: clinically relevant ultrasound, anatomical and histological findings.

Surgical and radiologic anatomy : SRA·2023

Same author

Development and validation of a minimally invasive and image-guided tape stripping method to sample atopic skin in children.

Clinical and experimental dermatology·2023

Same author

Effect of positive pressure ventilation and bariatric surgery on extracellular vesicle microRNAs in patients with severe obesity and obstructive sleep apnea.

International journal of obesity (2005)·2022

Search research articles

Related Experiment Videos

[Thyroid dysfunction in hospital worker population].

P Iglesias¹, J Lázaro, G Velasco

¹Hospital Ramón y Cajal, Madrid, España. piglo65@gmail.com

Revista Clinica Espanola

|September 21, 2010

Summary

The prevalence of thyroid dysfunction and thyroid autoimmunity in hospital employees is 14%. Increased anti-thyroid peroxidase antibody titers predict unknown thyroid dysfunction, particularly in women.

Related Experiment Videos

Area of Science:

Endocrinology
Immunology
Occupational Health

Context:

The prevalence of thyroid dysfunction (TD) and thyroid autoimmunity (TA) among hospital employees in Spain was previously unknown.
Hospital employees represent a unique occupational group potentially exposed to various environmental and occupational factors.

Purpose:

To determine the prevalence of TD and TA in a cohort of hospital employees.
To identify risk factors and predictors associated with TD and TA in this population.

Summary:

A study of 310 hospital employees (ages 18-70) in Segovia, Spain, revealed a total prevalence of 14.2% for TD and 14.2% for TA.
Subclinical hypothyroidism was the most common form of unknown TD. Both TD and TA were significantly associated with female sex.
Elevated anti-thyroid peroxidase (antiTPO) antibody titers were identified as a predictor of unknown TD (OR 1.007, P<0.001).

Impact:

This study provides crucial data on the prevalence of thyroid disorders in a healthcare worker population.
Findings highlight the importance of screening for thyroid dysfunction and autoimmunity in hospital employees, especially women.
Identifying antiTPO as a predictor of unknown TD can aid in early diagnosis and management, potentially improving employee health and reducing healthcare costs.